Children's Hospital Los Angeles | 100 Great Hospitals in America 2015
Children's Hospital Los Angeles. CHLA is a 365-bed nonprofit teaching hospital affiliated with University of Southern California's Keck School of Medicine. Founded in 1901 in a small two-bedroom house, CHLA admitted just 14 children in its first year. By 1905, admissions were up to 225 children.
Since then, CHLA has grown quite a bit. It clocks 14,600 annual inpatient visits, 343,753 outpatient visits and more than 72,000 ED visits. CHLA is staffed by more than 5,200 employees and nearly 650 clinicians across five departments: anesthesiology and critical care, pathology and laboratory medicine, pediatrics, radiology and surgery. It has the only freestanding Level I pediatric trauma center in Los Angeles both approved by the County Department of Health Services and accredited by the Committee on Trauma of the American College of Surgeons, and 106 pediatric critical-care beds. It is a Magnet-recognized hospital and one of just 10 hospitals to make the children's hospital U.S. News & World Report Honor Roll for 2014-15. It ranked nationally in all 10 pediatric specialties, and in the top 10 for six of them, including a No. 5 ranking for cancer, No. 7 for cardiology and heart surgery, No. 7 in diabetes and endocrinology, No. 9 in gastroenterology and GI surgery, No. 6 in neonatology and No. 2 in orthopedics.
CHLA is dedicated to education and trains 575 medical students, 85 full-time residents, three chief residents and 98 fellows. An overwhelming majority — 96 percent — graduate from CHLA's residency program and pass the pediatric board exam on the first try.
In their own words:
"Children’s Hospital Los Angeles (CHLA) is one of America's premier teaching hospitals, affiliated with the Keck School of Medicine of the University of Southern California (USC). We create hope and build healthier futures for children through scientific inquiry combined with clinical care devoted exclusively to children. From developing new methods for battling childhood leukemia to using leading-edge imaging technology to understand the origin of pediatric neurocognitive disorders and using a 3-D heart model to repair congenital heart defects in infants, innovation happens here."
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.